Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1995 Sep;4(5):355–358. doi: 10.1155/S0962935195000573

Circulating intercellular adhesion molecules in blood and bronchoalveolar lavage in Behçet's disease

A Hamzaoui 1, K Hamzaoui 2,✉, A Chabbou 3, K Ayed 4
PMCID: PMC2365663  PMID: 18475664

Abstract

The aim of this study was to evaluate circulating intercellular adhesion molecule-1 (cICAM-1) in serum and in bronchoalveolar lavage (BAL), as a marker for the inflammatory process in patients with active Behçet's disease (BD). Circulating ICAM-1 was tested by an enzyme linked immuno-sorbent assay in serum and in BAL of patients with BD. These values were compared to those of patients with tuberculosis and to healthy controls. Increased levels of circulating ICAM-1 were found in serum from patients with active BD compared to healthy controls (p < 0.01). Similar levels of serum cICAM-1 were found in BD and tuberculosis. Additionally, both BD and tuberculosis patients exhibited high levels of cICAM-1 in BAL fluid, suggesting that this increase may be a result of the immune system activation in inflammatory sites. Circulating ICAM-1 seemed to have a good discriminative power in identifying active BD, being elevated in all active stages (p < 0.01) compared to remission BD stage. No differences were found in active BD patients depending upon the clinical manifestations. These results suggest that cICAM-1 may be involved in leucocyte adhesion and migration into the vessel wall of the lung. Circulating forms are derived from molecules expressed on the surface of activated cells, as a result of an inflammatory process.

Full Text

The Full Text of this article is available as a PDF (375.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett S. T., McCarthy W. J., 3rd, Palmer A. S., Flinn W. R., Bergan J. J., Yao J. S. Multiple aneurysms in Behçet's disease. Arch Surg. 1988 Aug;123(8):1004–1008. doi: 10.1001/archsurg.1988.01400320090018. [DOI] [PubMed] [Google Scholar]
  2. Bouacha H., Azzabi S., Hamzaoui A., Kanzari A., Daoues A., Maalej M. Anévrysme de l'artère pulmonaire et infarctus pulmonaires multiples inaugurant la maladie de Behçet. Ann Med Interne (Paris) 1991;142(7):544–546. [PubMed] [Google Scholar]
  3. Erkan F., Cavdar T. Pulmonary vasculitis in Behçet's disease. Am Rev Respir Dis. 1992 Jul;146(1):232–239. doi: 10.1164/ajrccm/146.1.232. [DOI] [PubMed] [Google Scholar]
  4. Figdor C. G., van Kooyk Y., Keizer G. D. On the mode of action of LFA-1. Immunol Today. 1990 Aug;11(8):277–280. doi: 10.1016/0167-5699(90)90112-m. [DOI] [PubMed] [Google Scholar]
  5. Gamble C. N., Wiesner K. B., Shapiro R. F., Boyer W. J. The immune complex pathogenesis of glomerulonephritis and pulmonary vasculitis in Behçet's disease. Am J Med. 1979 Jun;66(6):1031–1039. doi: 10.1016/0002-9343(79)90461-3. [DOI] [PubMed] [Google Scholar]
  6. Hamzaoui K., Hamzaoui A., Hentati F., Kahan A., Ayed K., Chabbou A., Ben Hamida M., Hamza M. Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behçet's disease. J Rheumatol. 1994 Dec;21(12):2301–2306. [PubMed] [Google Scholar]
  7. Hamzaoui K., Hentati F., Hamzaoui A., Kahan A., Ben Hamida M., Chabbou A., Ayed K. CD11/CD18 bearing lymphocytes in cerebrospinal fluid from patients with active Behçet's disease. Clin Exp Rheumatol. 1994 Sep-Oct;12(5):575–576. [PubMed] [Google Scholar]
  8. Koch A. E., Haines G. K., Rizzo R. J., Radosevich J. A., Pope R. M., Robinson P. G., Pearce W. H. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol. 1990 Nov;137(5):1199–1213. [PMC free article] [PubMed] [Google Scholar]
  9. Lai C. K., Wong K. C., Chan C. H., Ho S. S., Chung S. Y., Haskard D. O., Lai K. N. Circulating adhesion molecules in tuberculosis. Clin Exp Immunol. 1993 Dec;94(3):522–526. [PMC free article] [PubMed] [Google Scholar]
  10. Leavitt R. Y., Fauci A. S. Pulmonary vasculitis. Am Rev Respir Dis. 1986 Jul;134(1):149–166. doi: 10.1164/arrd.1986.134.1.149. [DOI] [PubMed] [Google Scholar]
  11. Mege J. L., Dilsen N., Sanguedolce V., Gul A., Bongrand P., Roux H., Ocal L., Inanç M., Capo C. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993 Sep;20(9):1544–1549. [PubMed] [Google Scholar]
  12. Niwa Y., Miyake S., Sakane T., Shingu M., Yokoyama M. Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol. 1982 Jul;49(1):247–255. [PMC free article] [PubMed] [Google Scholar]
  13. O'Duffy J. D. Pulmonary involvement in Behçet's disease. Eur Respir J. 1993 Jul;6(7):936–937. [PubMed] [Google Scholar]
  14. Raz I., Okon E., Chajek-Shaul T. Pulmonary manifestations in Behçet's syndrome. Chest. 1989 Mar;95(3):585–589. doi: 10.1378/chest.95.3.585. [DOI] [PubMed] [Google Scholar]
  15. Ross R. Mechanisms of atherosclerosis--a review. Adv Nephrol Necker Hosp. 1990;19:79–86. [PubMed] [Google Scholar]
  16. Szekanecz Z., Shah M. R., Pearce W. H., Koch A. E. Intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms. Clin Exp Immunol. 1994 Nov;98(2):337–343. doi: 10.1111/j.1365-2249.1994.tb06147.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. van der Wal A. C., Das P. K., Tigges A. J., Becker A. E. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol. 1992 Dec;141(6):1427–1433. [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES